ABVC BioPharma, Inc.
USD1.80
+0.03 (+1.69%)
CEO
Uttam Yashwant Patil
IPO Date
2004-11-10
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$1.79
Prev. Close
$1.77
Day Low
$1.70
Day High
$1.80
52W Low
$0.88
52W High
$5.48
Market Cap
$0.03B
Volume
0.12M
| -1.4 |
| 31 Dec 2023 | FY | -98.1% | -5109.3% | -501.1% | -100.0% | 1.78 | 0.27 | -0.6 |
| 31 Dec 2022 | FY | 70.5% | -1693.5% | -368.8% | -150.2% | 0.77 | 0.54 | -1.2 |
| 31 Dec 2021 | FY | 98.6% | -3608.5% | -145.2% | -93.7% | 0.38 | 2.07 | -6.6 |
| 31 Dec 2020 | FY | 96.1% | -2027.0% | -148.4% | -66.3% | 1.03 | 1.27 | -10.3 |
| 31 Dec 2019 | FY | 97.1% | -519.0% | 2412.3% | -52.6% | -30.33 | 0.13 | -21.0 |
| 31 Dec 2018 | FY | -3190.5% | -80152.1% | 97.0% | -5791.2% | -0.14 | 0.02 | -76.7 |
| 31 Dec 2017 | FY | 0.0% | 0.0% | -256.6% | -64.2% | 0.74 | 0.19 | -100.0 |
| 30 Sept 2016 | FY | 0.0% | 0.0% | 168.8% | -59038.6% | 0.00 | 0.00 | -38.3 |
| 4.1 |
| 30 Sept 2025 | Q3 | 0.0% | 0.0% | -16.9% | -9.6% | 0.12 | 0.63 | -8.7 |
| 30 Jun 2025 | Q2 | 0.0% | 0.0% | -32.2% | -13.9% | 0.33 | 0.42 | -4.3 |
| 31 Mar 2025 | Q1 | 0.0% | 0.0% | -15.6% | -5.7% | 0.55 | 0.22 | -4.7 |
| 31 Dec 2024 | Q4 | 100.0% | 11663.5% | 18.7% | 3.0% | 2.61 | 0.33 | 8.6 |
| 30 Sept 2024 | Q3 | 99.9% | -47.9% | -2.2% | -1.3% | 0.33 | 0.34 | -11.4 |
| 30 Jun 2024 | Q2 | 99.8% | -804.4% | -11.4% | -6.4% | 0.33 | 0.33 | -2.5 |
| 31 Mar 2024 | Q1 | 77.0% | -235203.2% | -35.3% | -19.3% | 0.34 | 0.27 | -1.2 |
| 31 Dec 2023 | Q4 | -6329.8% | -143692.1% | -200.2% | -40.0% | 1.78 | 0.27 | -0.7 |